Precision and Recall in Variant Calling: How to Calculate and Interpret Performance Metrics

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-21

Key Takeaways

• Precision quantifies the proportion of called variants that are true positives (TP / (TP + FP)), indicating the reliability of reported variants. Recall quantifies the proportion of true variants that were successfully detected (TP / (TP + FN)), indicating the sensitivity of the variant caller.
• The confusion matrix is central to evaluating variant calling performance, categorizing outcomes into True Positives (TP), False Positives (FP), False Negatives (FN), and True Negatives (TN), though TNs are typically omitted due to their overwhelming abundance.
• Variant calling workflows significantly impact precision and recall; steps like read alignment, base quality recalibration, variant calling algorithms, and filtering stringency directly influence the balance between detecting true variants and avoiding false ones.
• Benchmarking against high-confidence truth sets, such as those provided by the Genome in a Bottle (GIAB) consortium, is crucial for assessing and comparing variant caller performance, particularly within defined high-confidence genomic regions.
• The choice between prioritizing precision or recall is application-dependent: high recall is critical for rare disease diagnosis to avoid missing causative variants, while high precision is essential for population-scale studies to prevent distortion of allele frequency estimates.
• Common failure patterns impacting accuracy include low recall in repetitive and low-complexity regions, low recall for structural variants, and high false positive rates in homopolymer regions, often necessitating specialized calling strategies or stringent filtering.

Variant calling accuracy is measured by comparing called variants against a trusted truth set, with precision and recall as the two core metrics. Precision tells you how many of the variants you reported are real, while recall tells you how many of the real variants you found. For researchers using whole-genome or targeted sequencing, these metrics determine whether your variant calls are trustworthy for downstream interpretation, filtering decisions, and biological conclusions. This article explains the confusion matrix in variant calling, provides worked calculation examples using benchmark truth sets such as Genome in a Bottle, and gives practical guidance for interpreting precision and recall tradeoffs in germline and somatic calling workflows.

The Role of Precision and Recall in Variant Calling

Variant calling is the computational process of identifying differences between a sequenced sample and a reference genome. These differences include single nucleotide variants (SNVs), small insertions and deletions (indels), and larger structural variants (SVs). The output of a variant caller is a list of candidate variants, typically stored in a VCF file, each with associated quality scores and genotype information.

The accuracy of this output cannot be assumed. Sequencing errors, mapping artifacts, low coverage regions, and repetitive genomic contexts all contribute to false positives. Conversely, true variants can be missed when coverage is insufficient or when the variant caller applies overly aggressive filtering. Precision and recall provide a quantitative framework for assessing both types of error.

Precision answers the question: of all variants you called, what fraction are genuine? Recall answers the question: of all genuine variants present in the sample, what fraction did you detect? These two metrics are always in tension. Increasing sensitivity to catch more true variants typically admits more false positives, lowering precision. Increasing specificity to remove false positives typically discards some true variants, lowering recall.

For germline variant calling, where the goal is to identify inherited variants in a diploid genome, precision and recall are usually evaluated against a high-confidence truth set from a well-characterized reference sample. For somatic variant calling, where the goal is to identify mutations present in tumor tissue but absent from matched normal tissue, the evaluation is complicated by tumor heterogeneity, varying allele fractions, and the absence of a perfect truth set.

The choice of variant calling workflow directly affects your precision and recall balance. Standard pipelines such as GATK have been widely adopted, but alternative workflows can achieve comparable accuracy with substantial gains in computational efficiency. One study comparing a workflow built from the LUSH toolkit against GATK found both pipelines achieved precision and recall rates exceeding 99% on a 30x NA12878 dataset, with the LUSH pipeline completing whole-genome analysis approximately 17 times faster than GATK. This demonstrates that precision and recall benchmarking is essential also for validating accuracy but also for comparing workflow performance in practical settings.

The Confusion Matrix in Variant Calling

The confusion matrix is a 2x2 table that categorizes the outcomes of a variant calling comparison against a truth set. Each variant position in the evaluated region is classified into one of four categories.

True positives (TP) are variants that appear in both your call set and the truth set. These are genuine variants that your caller correctly identified. False positives (FP) are variants in your call set that do not appear in the truth set. These are variants you reported that are not actually present in the sample. False negatives (FN) are variants in the truth set that your call set does not contain. These are genuine variants that your caller missed. True negatives (TN) are positions where neither your call set nor the truth set reports a variant. In variant calling, true negatives are usually not counted explicitly because the vast majority of genomic positions are non-variant, and including them would make precision and recall appear artificially high.

The confusion matrix for variant calling requires careful definition of what counts as a match. A variant in your call set matches a variant in the truth set only if it has the same genomic position, the same reference allele, the same alternate allele, and the same genotype. Some benchmarking tools allow partial credit for correct position with incorrect genotype, but the standard approach requires exact allele and genotype matching.

Constructing the confusion matrix requires a truth set. The Genome in a Bottle (GIAB) consortium, hosted by the National Center for Biotechnology Information, provides high-confidence variant calls for several well-characterized reference genomes. These truth sets are built from multiple sequencing technologies and platforms, with variants confirmed by orthogonal methods. Using a GIAB truth set allows you to evaluate your variant caller against a community-accepted standard.

The confusion matrix also depends on the genomic regions you include in the evaluation. GIAB provides high-confidence regions that exclude difficult genomic contexts such as segmental duplications, homopolymers, and low-complexity regions. Evaluating your calls only within these high-confidence regions gives a cleaner assessment of caller performance, but it does not reflect performance in the excluded regions where variant calling is substantially harder.

Calculating Precision and Recall from Benchmark Comparisons

Precision is calculated as the number of true positives divided by the total number of variants you called, which is the sum of true positives and false positives. The formula is:

Precision = TP / (TP + FP)

Recall is calculated as the number of true positives divided by the total number of true variants in the truth set, which is the sum of true positives and false negatives. The formula is:

Recall = TP / (TP + FN)

The F1 score combines both metrics into a single value using the harmonic mean:

F1 = 2 x (Precision x Recall) / (Precision + Recall)

The F1 score is useful when you need a single number to compare overall performance across different callers or parameter settings. It penalizes extreme imbalance between precision and recall, so a caller with very high precision but very low recall will have a low F1 score.

Consider a worked example. Suppose you run a variant caller on a whole-genome sample and compare the output against a GIAB truth set within the high-confidence regions. Your caller produces 4,500,000 variants. The comparison identifies 4,400,000 true positives and 100,000 false positives. The truth set contains 4,500,000 variants total, meaning your caller missed 100,000 true variants.

Precision = 4,400,000 / (4,400,000 + 100,000) = 0.978 or 97.8%

Recall = 4,400,000 / (4,400,000 + 100,000) = 0.978 or 97.8%

F1 = 2 x (0.978 x 0.978) / (0.978 + 0.978) = 0.978

Now consider a more aggressive caller that produces 4,700,000 variants. It finds 4,450,000 true positives but also 250,000 false positives. It misses only 50,000 true variants.

Precision = 4,450,000 / (4,450,000 + 250,000) = 0.947 or 94.7%

Recall = 4,450,000 / (4,450,000 + 50,000) = 0.989 or 98.9%

F1 = 2 x (0.947 x 0.989) / (0.947 + 0.989) = 0.967

The second caller has higher recall but lower precision and a lower F1 score. The choice between these two callers depends on your application. If you are screening for rare disease variants and cannot afford to miss a causative variant, higher recall may be preferable even at the cost of more false positives that require manual review. If you are conducting population-scale analysis where false positives would propagate through downstream analyses, higher precision may be more valuable.

At a Glance: Precision and Recall Decision Table

Variant Calling Workflow and Its Effect on Metrics

The variant calling workflow encompasses all steps from raw sequencing reads to the final VCF file. Each step influences precision and recall in different ways.

Read alignment is the first critical step. Reads must be mapped to the reference genome accurately for variant positions to be called correctly. Ambiguous mapping in repetitive regions leads to false variant calls or missed true variants. Low-copy repeats and segmental duplications are particularly problematic because reads from different copies of a repeat can map to the wrong location. Standard short-read variant callers exhibit low accuracy in these regions due to mapping ambiguity and extensive copy number variation. A multilocus approach that performs variant calling jointly across all repeat copies can achieve higher precision and recall in low-copy repeat regions compared to standard callers.

Base quality score recalibration adjusts the quality scores assigned to each base call by the sequencer. Machine learning models learn systematic errors from the sequencing platform and correct the quality scores accordingly. This step primarily affects precision by reducing the number of low-quality bases that pass the quality threshold and contribute to false variant calls.

Variant calling itself involves statistical models that evaluate the evidence for each candidate variant. The caller considers the number of reads supporting each allele, the base qualities, the mapping qualities, and the expected allele fraction based on ploidy. Germline callers assume diploid genotypes and expect allele fractions near 0.5 for heterozygous variants and 1.0 for homozygous variants. Somatic callers compare tumor and normal samples to identify variants present only in the tumor.

Variant filtering is the final step before the call set is considered complete. Filters remove variants based on quality scores, depth, allele fraction, strand bias, and other annotations. The stringency of filtering directly trades precision against recall. Stringent filters remove more false positives but also remove some true variants with borderline quality. Relaxed filters retain more true variants but admit more false positives.

Population data can be incorporated into variant calling to improve accuracy. Large-scale population variant databases are often used to filter variants after calling, but this approach trades recall for precision because it removes variants that are not seen in the population reference. A population-aware approach that incorporates allele frequencies directly into the variant calling model can reduce errors and improve both precision and recall simultaneously. This demonstrates that the choice of variant calling algorithm matters as much as the filtering strategy.

Germline Variant Calling: Precision and Recall Considerations

Germline variant calling identifies variants inherited from parents and present in every cell of the individual. The expected allele fraction is 0.5 for heterozygous variants and 1.0 for homozygous variants, assuming diploidy and no copy number alterations. This expectation simplifies the statistical model and allows for relatively high precision and recall compared to somatic calling.

The standard approach for germline calling uses short-read sequencing at 30x coverage or higher. At this coverage, most variant positions have sufficient read depth to make confident calls. The precision and recall of standard pipelines on well-characterized samples are typically above 99% for SNVs in high-confidence regions. Indels are more challenging, with lower precision and recall due to alignment ambiguity around the variant site.

Long-read sequencing offers advantages for germline variant calling. Long reads span repetitive regions and structural variant breakpoints that are inaccessible to short reads. A study comparing Oxford Nanopore Technologies and Pacific Biosciences HiFi platforms found that long-read sensitivity begins to plateau around 12-fold coverage, with the majority of variants called with reasonable accuracy. Genome assembly from long reads increases variant calling precision and recall for structural variants and indels compared to read-based approaches.

Coverage is a key determinant of precision and recall in germline calling. Low coverage reduces the number of reads supporting each variant, making it harder to distinguish true variants from sequencing errors. The tradeoff between sequence coverage and sensitivity of variant discovery is an important experimental consideration. Researchers designing cost-effective studies must decide whether reduced coverage with lower recall is acceptable for their research question.

For clinical germline testing, precision is prioritized because reported variants must be defensible. False positive variants in a clinical report can lead to incorrect diagnosis and inappropriate medical management. Clinical laboratories typically confirm candidate variants with orthogonal methods such as Sanger sequencing before reporting. This confirmation step effectively increases precision at the cost of additional time and expense.

Somatic Variant Calling: Unique Precision and Recall Challenges

Somatic variant calling identifies mutations that arise in somatic tissues, typically in the context of cancer. The tumor sample contains a mixture of tumor cells and normal cells, and the variant allele fraction depends on the purity of the tumor sample and the clonality of the mutation. Variant allele fractions can range from near 50% for clonal heterozygous mutations in pure tumor samples to below 1% for subclonal mutations in impure samples.

The low variant allele fractions in somatic calling create a fundamental challenge for precision and recall. Sequencing errors occur at rates that can exceed the variant allele fraction of true subclonal mutations. Distinguishing a true mutation present in 2% of reads from a sequencing error requires either very high coverage or sophisticated error models.

Somatic calling typically requires a matched normal sample from the same individual. The normal sample provides a baseline for distinguishing germline variants from somatic mutations. Variants present in both tumor and normal samples are germline and should not be reported as somatic. Variants present only in the tumor are candidate somatic mutations. The comparison between tumor and normal samples introduces additional sources of error, including differences in coverage and sequencing artifacts between the two libraries.

The precision and recall of somatic calling depend heavily on coverage. Deep sequencing of the tumor sample, often 100x or higher, is required to detect mutations at low allele fractions. Even with deep coverage, the precision of somatic calls at low allele fractions is limited by the error rate of the sequencing platform. Researchers must decide on a minimum variant allele fraction threshold that balances the need to detect subclonal mutations against the risk of reporting false positives.

Somatic structural variant detection faces similar challenges. Structural variants in tumors can be complex, with breakpoints in repetitive regions and copy number alterations that complicate interpretation. Long-read sequencing provides advantages for somatic structural variant detection because long reads can span breakpoints and resolve complex rearrangements.

Variant Filtering Strategies and Their Impact on Metrics

Variant filtering is the primary tool for controlling the precision and recall balance of your final call set. The filtering strategy should be informed by your research question and the downstream use of the variant calls.

Quality score filtering is the most common approach. Variant callers assign a quality score to each variant based on the probability that the variant is real. Higher quality scores indicate higher confidence. Setting a quality threshold removes variants below the threshold. Increasing the threshold improves precision but reduces recall. The optimal threshold depends on the caller, the sequencing platform, and the application.

Depth filtering removes variants with insufficient read support. A minimum depth threshold ensures that each variant is supported by enough reads to be confident. Low-depth variants are more likely to be false positives because they are based on limited evidence. However, true variants in low-coverage regions will also be removed, reducing recall.

Allele fraction filtering removes variants with variant allele fractions below a threshold. This is particularly important in somatic calling, where low allele fraction variants may be sequencing errors. In germline calling, allele fraction filtering is less commonly used because heterozygous variants are expected at 0.5 allele fraction, and deviations from this expectation may indicate copy number alterations or mosaicism.

Strand bias filtering removes variants where the supporting reads are predominantly from one strand. Strand bias can indicate mapping artifacts or sequencing errors. However, some true variants exhibit strand bias due to local sequence context, so aggressive strand bias filtering can reduce recall.

Population frequency filtering removes variants that are common in population databases. This is based on the assumption that common variants are unlikely to be pathogenic. In germline rare disease analysis, variants with population allele frequency above a threshold are typically filtered out. This filtering trades recall for precision because it removes true variants that happen to be common in the population.

The choice of filtering strategy should be validated using a truth set. Running your filtering pipeline on a sample with known variants allows you to measure precision and recall at different filter thresholds and select the threshold that achieves the desired balance. This validation should be performed on data from the same sequencing platform and coverage as your actual samples.

Benchmarking Tools and Truth Sets

Benchmarking variant calls requires a truth set of known variants in a reference sample. The Genome in a Bottle consortium provides high-confidence variant calls for several reference genomes, including NA12878, HG002, HG003, and HG004. These truth sets are built from multiple sequencing technologies and platforms, with variants confirmed by orthogonal methods. The high-confidence regions exclude difficult genomic contexts where variant calling is unreliable.

The National Center for Biotechnology Information provides access to these truth sets and the associated reference genomes. Researchers can download the truth set VCF files and the high-confidence region BED files for use in benchmarking their own variant callers.

Benchmarking tools compare your call set against the truth set and compute precision, recall, and F1 score. These tools handle the details of matching variants between call sets, including normalization of variant representation and handling of complex variants. The choice of benchmarking tool can affect the results, so consistency in benchmarking methodology is important when comparing different callers or parameter settings.

The choice of truth set affects the interpretation of precision and recall. A truth set built from short-read data will not include structural variants that are only detectable by long-read sequencing. Evaluating a long-read caller against a short-read truth set will show low recall for structural variants even if the caller is performing well. Conversely, evaluating a short-read caller against a long-read truth set will show low recall in regions that short reads cannot access.

For somatic variant calling, truth sets are more challenging to construct. There is no equivalent to Genome in a Bottle for somatic mutations because each tumor is unique. Instead, researchers use synthetic spike-in experiments where known mutations are added to a sample at defined allele fractions, or they use cell line mixtures with known mutations. These approaches provide a ground truth for benchmarking but do not capture the full complexity of real tumor samples.

Practical Steps for Calculating Precision and Recall

To calculate precision and recall for your variant calling pipeline, follow these steps.

First, obtain a truth set for a reference sample that matches your sequencing platform and coverage. The Genome in a Bottle truth sets are appropriate for human germline variant calling. If you are using a non-human organism, you may need to construct your own truth set using orthogonal methods such as Sanger sequencing or a combination of multiple sequencing platforms.

Second, run your variant calling pipeline on the sequencing data for the reference sample. Use the same parameters and filters that you would use for your actual samples. The benchmarking results are only meaningful if they reflect your actual pipeline.

Third, run a benchmarking tool to compare your call set against the truth set. The tool will produce a classification of each variant as a true positive, false positive, or false negative, and will compute precision, recall, and F1 score.

Fourth, examine the variants that are classified as false positives and false negatives. False positives may indicate systematic errors in your pipeline that can be corrected. False negatives may indicate regions of the genome where your caller has poor sensitivity.

Fifth, adjust your filtering parameters based on the benchmarking results. If precision is too low, increase the stringency of your filters. If recall is too low, decrease the stringency. Repeat the benchmarking after each adjustment to measure the effect.

Sixth, document the precision and recall of your pipeline in your methods. This documentation allows other researchers to assess the reliability of your variant calls and to compare your results with other studies.

Records and Measurements for Variant Calling Accuracy

Maintaining records of variant calling accuracy is essential for reproducible research and for tracking the performance of your pipeline over time. The following measurements should be recorded for each benchmarking run.

The version of the reference genome and the truth set should be recorded. Reference genome versions change over time, and truth sets are updated as new data become available. Precision and recall values are only comparable when the same reference and truth set are used.

The version of each tool in the pipeline should be recorded. Variant callers and benchmarking tools are updated frequently, and updates can change precision and recall. Recording tool versions allows you to identify the source of changes in performance.

The sequencing platform, coverage, and read length should be recorded. These sequencing parameters have a direct effect on precision and recall. A pipeline that achieves high precision and recall at 30x coverage may perform poorly at 10x coverage.

The filtering parameters should be recorded. The quality threshold, depth threshold, and other filter settings determine the precision and recall balance. Recording these parameters allows you to reproduce the exact call set.

The precision, recall, and F1 score should be recorded for each benchmarking run. These values provide a quantitative summary of pipeline performance. Tracking these values over time allows you to detect changes in performance due to tool updates or changes in sequencing conditions.

The number of true positives, false positives, and false negatives should be recorded. These raw counts provide more information than precision and recall alone. A pipeline with high precision and recall may still have a large number of false positives if the truth set contains many variants.

Common Failure Patterns in Variant Calling Accuracy

Several common failure patterns can reduce precision and recall in variant calling. Recognizing these patterns allows you to diagnose problems in your pipeline and take corrective action.

Low recall in repetitive regions is a common failure pattern. Short reads cannot uniquely map to repetitive regions, so variants in these regions are missed. This is particularly problematic in low-copy repeats and segmental duplications, which cover more than 5% of the human genome. Standard variant callers exhibit low accuracy in these regions due to mapping ambiguity. Specialized approaches that perform variant calling jointly across all repeat copies can improve both precision and recall in these regions.

Low recall for structural variants is another common failure pattern. Short-read sequencing cannot span large structural variant breakpoints, so these variants are missed. Long-read sequencing provides significant advantages for structural variant detection, including access to previously excluded genomic regions and discovery of more complex structural variants. Genome assembly from long reads further improves structural variant precision and recall.

High false positive rates in homopolymer regions are a common failure pattern. Homopolymers are runs of the same nucleotide, and sequencing errors are common in these regions due to polymerase slippage. Variant callers may report false indels in homopolymer regions. Filtering based on the length of the homopolymer and the position of the variant within the homopolymer can reduce these false positives.

Low recall for rare variants is a common failure pattern in population-scale studies. Rare variants are present in few individuals, so they have limited evidence in any single sample. Variant callers may miss rare variants because the evidence does not reach the significance threshold. Incorporating population data into the variant calling model can improve recall for rare variants.

High false positive rates in low-complexity regions are a common failure pattern. Low-complexity regions have repetitive sequence content that causes alignment artifacts. Variant callers may report false variants in these regions due to misalignment. Excluding low-complexity regions from analysis or applying stringent filters in these regions can reduce false positives.

Limitations of Precision and Recall in Variant Calling

Precision and recall are powerful metrics, but they have important limitations that researchers must understand.

Precision and recall are only as good as the truth set. If the truth set contains errors, the precision and recall values will be inaccurate. Truth sets are built from multiple technologies and platforms, but they are not perfect. Variants that are difficult to call with any technology may be missing from the truth set, leading to underestimation of recall.

Precision and recall are typically evaluated only in high-confidence regions. The Genome in a Bottle truth sets define high-confidence regions that exclude difficult genomic contexts. Performance in these regions does not reflect performance in the excluded regions, where variant calling is substantially harder. A pipeline that achieves high precision and recall in high-confidence regions may perform poorly in the excluded regions.

Precision and recall are aggregate metrics that do not capture variation across the genome. A pipeline may have high overall precision and recall but poor performance in specific genomic contexts. Examining precision and recall stratified by genomic context can reveal these patterns.

Precision and recall are sensitive to the variant representation. The same variant can be represented in different ways in different VCF files, particularly for indels and complex variants. Benchmarking tools normalize variant representation before comparison, but normalization is not always perfect. Differences in variant representation can lead to apparent differences in precision and recall that are not biologically meaningful.

Precision and recall do not capture all aspects of variant calling accuracy. Genotype accuracy is a separate metric that measures how often the called genotype matches the true genotype. A variant can be correctly identified as present but assigned the wrong genotype. Genotype accuracy is particularly important for clinical applications where the distinction between heterozygous and homozygous variants has medical implications.

Safety and Regulatory Context for Variant Calling Accuracy

Variant calling accuracy has direct implications for clinical and regulatory applications. In clinical diagnostics, variant calls are used to guide medical management, including diagnosis, prognosis, and treatment selection. False positive variants can lead to incorrect diagnosis and inappropriate treatment. False negative variants can lead to missed diagnosis and delayed treatment.

Clinical laboratories must validate their variant calling pipelines before use in patient samples. Validation typically involves benchmarking against truth sets and demonstrating that precision and recall meet established thresholds. The specific thresholds depend on the application and the regulatory requirements of the jurisdiction.

The precision and recall of a variant calling pipeline are not static properties. They depend on the sequencing platform, coverage, sample type, and genomic context. Clinical laboratories must establish the performance characteristics of their pipeline for the specific conditions under which it will be used.

For somatic variant calling in cancer, the precision and recall of the pipeline affect treatment decisions. Targeted therapies are selected based on the presence of specific mutations. A false positive mutation could lead to treatment with a therapy that is ineffective or harmful. A false negative mutation could lead to failure to offer a therapy that would be beneficial.

The regulatory landscape for variant calling is evolving. Regulatory agencies are developing frameworks for evaluating the analytical validity of bioinformatics pipelines. Researchers and laboratories should stay informed about the regulatory requirements in their jurisdiction and ensure that their pipelines meet the required standards.

Professional Escalation Criteria for Variant Calling Problems

Researchers should escalate variant calling problems to a bioinformatics specialist or a more experienced colleague when certain conditions are met.

If precision or recall falls below the threshold required for your application, escalate the problem. The threshold depends on the application. Clinical applications typically require higher precision and recall than research applications. If your benchmarking results do not meet the required threshold, you need expert assistance to diagnose and correct the problem.

If precision and recall vary substantially across samples, escalate the problem. Consistent performance across samples is expected when the sequencing conditions are consistent. Variation in performance may indicate sample-specific issues such as contamination, degradation, or batch effects.

If precision and recall change after a tool update, escalate the problem. Tool updates can change variant calling behavior in unexpected ways. A change in precision and recall after an update may indicate a bug in the new version or a change in the default parameters.

If you observe a high rate of false positives in a specific genomic region, escalate the problem. This may indicate a systematic error in your pipeline that requires specialized tools or approaches to correct.

If you are unable to achieve the required precision and recall with your current sequencing data, escalate the problem. The problem may be insufficient coverage, inappropriate sequencing platform, or a mismatch between the sequencing strategy and the research question.

Frequently Asked Questions

What is the difference between precision and recall in variant calling?

Precision measures the fraction of your called variants that are true positives, calculated as true positives divided by the total number of variants you called. Recall measures the fraction of true variants that you detected, calculated as true positives divided by the total number of true variants in the truth set. High precision means few false positives in your call set. High recall means few false negatives, meaning you are not missing many true variants.

How do I choose between precision and recall for my variant calling pipeline?

The choice depends on your application. For clinical diagnosis where missing a causative variant has serious consequences, prioritize recall. For population-scale studies where false variants distort downstream analyses, prioritize precision. For most research applications, aim for a balanced approach and report both metrics along with the F1 score.

What is a good precision and recall value for variant calling?

Standard germline variant calling pipelines on well-characterized samples at 30x coverage typically achieve precision and recall above 99% for SNVs in high-confidence regions. Indels and structural variants have lower precision and recall. Somatic variant calling has lower precision and recall, particularly for mutations at low allele fractions. The acceptable values depend on your application and the genomic context.

How does sequencing coverage affect precision and recall?

Higher coverage generally improves both precision and recall because more reads provide more evidence for each variant. However, the relationship is not linear. Long-read sequencing sensitivity begins to plateau around 12-fold coverage, with the majority of variants called with reasonable accuracy. The optimal coverage depends on the sequencing platform, the variant types of interest, and the required precision and recall.

What is the Genome in a Bottle truth set and how do I use it?

The Genome in a Bottle consortium provides high-confidence variant calls for several reference genomes, built from multiple sequencing technologies and platforms. The truth set includes a VCF file of high-confidence variants and a BED file of high-confidence regions. You compare your call set against the truth set within the high-confidence regions to calculate precision and recall. The National Center for Biotechnology Information provides access to these truth sets.

How do I calculate precision and recall for somatic variant calling?

Somatic variant calling requires a matched normal sample and a truth set that reflects the known mutations in the tumor sample. Synthetic spike-in experiments or cell line mixtures with known mutations provide ground truth for benchmarking. The calculation of precision and recall is the same as for germline calling, but the truth set is constructed differently and the variant allele fraction threshold is a critical parameter.

Why is my recall lower for indels and structural variants than for SNVs?

Indels and structural variants are harder to detect than SNVs because they involve changes in sequence length that complicate read alignment. Short reads cannot span large structural variant breakpoints, and alignment ambiguity around indel sites reduces calling accuracy. Long-read sequencing and genome assembly approaches can improve precision and recall for these variant types.

How often should I benchmark my variant calling pipeline?

Benchmark your pipeline whenever you change any component of the workflow, including the variant caller, the filtering parameters, the reference genome, or the sequencing platform. Also benchmark when you update any tool in the pipeline, because updates can change behavior. Regular benchmarking on a reference sample provides a baseline for detecting changes in performance over time.

Related Bioinformatics Guides

• Volcano Plot Proteomics: How to Create and Interpret Them Effectively
• Detecting Structural Variants with Long-Read Sequencing: Methods and Considerations
• How to Interpret Gene Set Enrichment Analysis Results
• Genomic Data Analysis Tools: A Comparative Guide for Researchers
• Metagenomic Binning Tools Benchmark: How to Evaluate and Choose

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

• NCBI Data Resources. National Center for Biotechnology Information.
• EMBL-EBI Training. European Bioinformatics Institute.
• Bioconductor. Bioconductor Project.
• Galaxy Training Network. Galaxy Project.
• nf-core Documentation. nf-core.
• The Carpentries Lessons. The Carpentries.
• Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall.. Genome research, 2023.
• Whole-genome long-read sequencing downsampling and its effect on variant calling precision and recall.. bioRxiv : the preprint server for biology, 2023.
• Fast and accurate DNASeq variant calling workflow composed of LUSH toolkit.. Human genomics, 2024.
• Improving variant calling using population data and deep learning.. BMC bioinformatics, 2023.
• A multilocus approach for accurate variant calling in low-copy repeats using whole-genome sequencing.. Bioinformatics (Oxford, England), 2023.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.